TrialBMC gastroenterology2019

Sustained serological and complete responses in HBeAg-positive patients treated with Peginterferon alfa-2b: a 6-year long-term follow-up of a multicenter, randomized, controlled trial in China.

Jian Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.